Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTO.L Regulatory News (CTO)

  • There is currently no data for CTO

Trading Statement

30 Jan 2020 07:00

RNS Number : 3397B
TClarke PLC
30 January 2020
 

 

TClarke plc

Year End Trading Update

 

TCLARKE ACHIEVES 3% UNDERLYING OPERATING MARGIN,

STRONG EPS GROWTH AND IS DEBT FREE

 

TClarke plc ("TClarke" or the "Group"), the Building Services Group, announces a year end trading update for the financial year ended 31st December 2019.

 

Financial Results

The Board is pleased to report that the expected outcome for the year is in line with expectations as outlined in the trading update released to shareholders on 28th November 2019. We expect to report an increase in underlying operating profit before interest and taxation to approximately £10.2m (2018: £8.8m) and revenue growth to approximately £335m (2018: £327m). We are pleased to have achieved a 3.0% operating margin (2018: 2.7%), which is a strategic objective of the Group. As a result, underlying earnings per share have grown by approximately 14% to 17.5p (2018 15.4p).

 

Cash

The Group's cash position remains robust, with the year-end cash position at £12.4m (2018 cash £12.4m).

 

The Group has available bank facilities comprising a £10m overdraft facility and a £15m revolving credit facility expiring on 31st August 2022. These facilities remain available to the Group to support our working capital demands throughout the year. At 31st December 2019, the Group was debt free with none of the facilities being utilised.

 

Order Book

Our established strategy is to selectively target projects that we believe will add value and sustain the margin profile of the Group. At 31st December 2019, the forward order book stood at close to our record position of £403m (2018: £411m). Importantly, 76% of our turnover for the current financial year of 2020 has been secured, including four significant new London schemes.

 

Outlook

The Board remains encouraged by the continued opportunities available to the Group, particularly on high profile projects working with clients who value TClarke's ability to deliver large, complex projects successfully. We remain focussed on supporting our sustainable operating margin at 3% going forward and will continue to adhere to a strict bidding policy when looking at these opportunities.

 

The Group enters the new year in a strong position both operationally and financially which gives the Board confidence for the Group's prospects for 2020 and beyond.

 

Mark Lawrence, CEO, commented:

 

"We are delighted with the performance of the Group over the year. Our margin target has been achieved and we have maintained our strong Balance Sheet with a net cash position at the end of the year of over £12m. Looking ahead, our order book has been boosted and stands at over £400m and we have a solid pipeline of opportunities that we are evaluating carefully. The outlook for 2020 remains positive and the Board is confident of delivering further growth in 2020.''

 

TClarke plc will be announcing its 2019 preliminary results on Thursday, 19th March 2020.

 

Ends

 

30th January 2020

 

For further information contact:

 

TClarke plc

Mark Lawrence - Group Chief Executive

Trevor Mitchell - Finance Director

David Lanchester - Company Secretary

Tel: 020 7997 7400

www.tclarke.co.uk

 

Cenkos Securities plc (Corporate Broker)

Max Hartley (Corporate Finance)

Nick Searle (Sales)

Tel: 020 7397 8900

www.cenkos.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUPWGUPUGAB
Date   Source Headline
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor
22nd Jun 20229:37 amRNSTotal Voting Rights
17th May 20227:00 amRNSTClarke to Present at Mello Investor Conference
11th May 202210:27 amRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
10th May 202212:51 pmRNSESOT Share Purchase
5th May 20223:52 pmRNSESOT Share Purchase
3rd May 20229:03 amRNSDirector/PDMR Shareholding
26th Apr 20224:29 pmRNSVesting of EIP share awards April 2022
20th Apr 20229:27 amRNSChange of Registered Office
8th Apr 202210:09 amRNSPublication of Annual Report and Notice of AGM
8th Apr 20227:00 amRNSDirectorate Change
16th Mar 20228:27 amRNSDirector/PDMR Shareholding
16th Mar 20228:21 amRNSTotal Voting Rights
11th Mar 20227:00 amRNSInvestor Presentation
9th Mar 20227:02 amRNSDirectorate Change
9th Mar 20227:00 amRNSNotification of Investor Presentation
9th Mar 20227:00 amRNSFinal Results
2nd Feb 20223:21 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSNotification of Investor Presentation
27th Jan 20227:00 amRNSTrading Statement
4th Jan 202211:28 amRNSBlock listing Interim Review
9th Dec 20211:11 pmRNSESOT Share Purchase
6th Dec 20219:40 amRNSESOT Share Purchase
3rd Dec 202111:51 amRNSTR-1: Notification of Change of Holding
1st Dec 20213:02 pmRNSPDMR Disclosure
1st Dec 20213:00 pmRNSTotal Voting Rights and Share Capital
25th Nov 20217:00 amRNSTrading Statement
18th Oct 20217:00 amRNSInvestor Presentation
6th Oct 202111:14 amRNSPDMR Holding
6th Oct 202111:10 amRNSBlock Listing Application
22nd Sep 20217:00 amRNSNotice of Investor Presentation
17th Aug 20211:41 pmRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSTClarke Selected for NHS Smart Buildings Framework
20th Jul 20217:00 amRNSHalf-year Report
5th Jul 20217:00 amRNSBlock listing Interim Review
1st Jul 20217:00 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights
6th May 20219:04 amRNSTR-1: Notification of major holding in Company
5th May 202111:20 amRNSResult of AGM
5th May 20217:01 amRNSDirectorate Change
5th May 20217:00 amRNSAGM - Trading Update
29th Apr 20217:00 amRNSDirector / PDMR Shareholding
28th Apr 20217:00 amRNSDirector / PDMR Shareholding
12th Apr 202110:40 amRNSESOT Share Purchase
9th Apr 20212:53 pmRNSPublication of Annual Report & Notice of 2021 AGM
6th Apr 202110:39 amRNSESOT Share Purchase
26th Mar 20212:28 pmRNSESOT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.